Cargando…
Editorial: Engineered Targeted Cancer Immunotherapies
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291399/ https://www.ncbi.nlm.nih.gov/pubmed/35860563 http://dx.doi.org/10.3389/fonc.2022.953175 |
| _version_ | 1784749129805594624 |
|---|---|
| author | Fantini, Massimo Bei, Roberto |
| author_facet | Fantini, Massimo Bei, Roberto |
| author_sort | Fantini, Massimo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9291399 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92913992022-07-19 Editorial: Engineered Targeted Cancer Immunotherapies Fantini, Massimo Bei, Roberto Front Oncol Oncology Frontiers Media S.A. 2022-07-04 /pmc/articles/PMC9291399/ /pubmed/35860563 http://dx.doi.org/10.3389/fonc.2022.953175 Text en Copyright © 2022 Fantini and Bei https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Fantini, Massimo Bei, Roberto Editorial: Engineered Targeted Cancer Immunotherapies |
| title | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_full | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_fullStr | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_full_unstemmed | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_short | Editorial: Engineered Targeted Cancer Immunotherapies |
| title_sort | editorial: engineered targeted cancer immunotherapies |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291399/ https://www.ncbi.nlm.nih.gov/pubmed/35860563 http://dx.doi.org/10.3389/fonc.2022.953175 |
| work_keys_str_mv | AT fantinimassimo editorialengineeredtargetedcancerimmunotherapies AT beiroberto editorialengineeredtargetedcancerimmunotherapies |